A Wake-Up Call for ME/CFS? The Solriamfetol / Sunosi Trial Improves Daytime Fatigue and Cognition
The small Sunosi ME/CFS trial improved daytime fatigue, planning and organizing, and symptoms.
Could ME/CFS and Fibromyalgia Be Narcoleptic Spectrum Disorders?
Could ME;/CFS and fibromyalgia be on the narcoleptic disease spectrum? After decades of work on these diseases, Dr. Perrino believes so...
Tonmya is FDA Approved to Treat Fibromyalgia: CEO Seth Lederman Talks
Tonmya is the first FDA approved drug for use in fibromyalgia in 15 years. Seth Lederman, CEO of Tonix Pharmaceuticals, talked about how the drug was developed, what it does, and when it will become available.
Too Much Exertion Produces Autonomic Nervous System Hit in Long COVID, ME/CFS, and Fibromyalgia
Geoff’s Narrations The GIST The Blog A trip to Seattle to see Dr. Ruhoy held up the blogs a bit but they’re back! Exercise physiologist Rob Wust’s “Wearable heart rate variability monitoring identifies autonomic dysfunction and...
High Default Mode Network Activity in ME/CFS Associated with Decreased Alertness, Difficulty Carrying out Tasks and More
Alertness, the ability to carry out tasks, sleep and others in chronic fatigue syndrome are impacted by activation of the default mode network in the brain.StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
